Tags

Type your tag names separated by a space and hit enter

Prognostic Roles of Central Carbon Metabolism-Associated Genes in Patients With Low-Grade Glioma.
Front Genet 2019; 10:831FG

Abstract

Purpose:

Metabolic alterations are crucial for tumor progression and response to therapy. The comprehensive model of combined central carbon metabolism-associated genes that contribute to the outcomes of glioma and astrocytoma is not well understood. Method: We studied the profiles of 63 genes involved in central carbon metabolism in 514 relatively low-grade glioma patients. The different distributions of gene expression in gliomas and astrocytoma were identified. The differential gene expression between each cohort and the correlations with prognosis were detected. Finally, we built a tentative model to detect the prognostic roles of carbon metabolism-associated genes in astrocytoma. Result: Two primary clusters and four subclusters with significantly different overall survival were identified in low-grade glioma. The differences of histological diagnoses, grade, tumor site, and age were detected between each cluster. Comparing with other histological types, patients with astrocytoma exhibited the worst prognosis. Between astrocytoma patients with poor and favorable prognoses, expression profiles of 11 genes were significantly discrepant. We detected that 18 genes were respectively correlated with overall survival in astrocytoma; moreover, four genes (RAF1, AKT3, IDH1, and FGFR1) were detected as dependent variables for the prediction of the survival status of astrocytoma patients and were capable to predict the survival.

Conclusion:

Central carbon metabolism-associated genes are differentially expressed in all patients with glioma and histological subtype astrocytoma. The gene expression profile is significantly associated with clinical manifestations. These results suggested that both the multigene expression patterns and individual central carbon metabolism-associated genes were potentially capable to predict the prognosis of patients with low-grade glioma.

Authors+Show Affiliations

Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31620163

Citation

Wang, Li, et al. "Prognostic Roles of Central Carbon Metabolism-Associated Genes in Patients With Low-Grade Glioma." Frontiers in Genetics, vol. 10, 2019, p. 831.
Wang L, Guo M, Wang K, et al. Prognostic Roles of Central Carbon Metabolism-Associated Genes in Patients With Low-Grade Glioma. Front Genet. 2019;10:831.
Wang, L., Guo, M., Wang, K., & Zhang, L. (2019). Prognostic Roles of Central Carbon Metabolism-Associated Genes in Patients With Low-Grade Glioma. Frontiers in Genetics, 10, p. 831. doi:10.3389/fgene.2019.00831.
Wang L, et al. Prognostic Roles of Central Carbon Metabolism-Associated Genes in Patients With Low-Grade Glioma. Front Genet. 2019;10:831. PubMed PMID: 31620163.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prognostic Roles of Central Carbon Metabolism-Associated Genes in Patients With Low-Grade Glioma. AU - Wang,Li, AU - Guo,Meng, AU - Wang,Kai, AU - Zhang,Lei, Y1 - 2019/09/18/ PY - 2019/05/08/received PY - 2019/08/12/accepted PY - 2019/10/18/entrez PY - 2019/10/18/pubmed PY - 2019/10/18/medline KW - astrocytoma KW - gene expression KW - low-grade glioma KW - metabolism KW - prognosis SP - 831 EP - 831 JF - Frontiers in genetics JO - Front Genet VL - 10 N2 - Purpose: Metabolic alterations are crucial for tumor progression and response to therapy. The comprehensive model of combined central carbon metabolism-associated genes that contribute to the outcomes of glioma and astrocytoma is not well understood. Method: We studied the profiles of 63 genes involved in central carbon metabolism in 514 relatively low-grade glioma patients. The different distributions of gene expression in gliomas and astrocytoma were identified. The differential gene expression between each cohort and the correlations with prognosis were detected. Finally, we built a tentative model to detect the prognostic roles of carbon metabolism-associated genes in astrocytoma. Result: Two primary clusters and four subclusters with significantly different overall survival were identified in low-grade glioma. The differences of histological diagnoses, grade, tumor site, and age were detected between each cluster. Comparing with other histological types, patients with astrocytoma exhibited the worst prognosis. Between astrocytoma patients with poor and favorable prognoses, expression profiles of 11 genes were significantly discrepant. We detected that 18 genes were respectively correlated with overall survival in astrocytoma; moreover, four genes (RAF1, AKT3, IDH1, and FGFR1) were detected as dependent variables for the prediction of the survival status of astrocytoma patients and were capable to predict the survival. Conclusion: Central carbon metabolism-associated genes are differentially expressed in all patients with glioma and histological subtype astrocytoma. The gene expression profile is significantly associated with clinical manifestations. These results suggested that both the multigene expression patterns and individual central carbon metabolism-associated genes were potentially capable to predict the prognosis of patients with low-grade glioma. SN - 1664-8021 UR - https://www.unboundmedicine.com/medline/citation/31620163/Prognostic_Roles_of_Central_Carbon_Metabolism-Associated_Genes_in_Patients_With_Low-Grade_Glioma L2 - https://doi.org/10.3389/fgene.2019.00831 DB - PRIME DP - Unbound Medicine ER -
Unbound Prime app for iOS iPhone iPadUnbound PubMed app for AndroidAlso Available:
Unbound MEDLINE
Unbound PubMed app for Windows